Campylobacter jejuni and associated immune mechanisms: Short-term effects and long-term implications for infants in low-income countries

Current Opinion in Infectious Diseases

Volumn 30, Issue 3, 2017, Pages 322-328

  Schnee, Amanda E ^a   Petri, William A ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Campylobacter jejuni; Environmental enteric dysfunction; Inflammation; Malnutrition; Microbiota

Indexed keywords

ADAPTIVE IMMUNITY; BACTERIAL VIRULENCE; CAMPYLOBACTER ENTERITIS; CAMPYLOBACTER JEJUNI; HUMAN; INFANT; INFANT DISEASE; INFLAMMATION; INNATE IMMUNITY; INTESTINE FLORA; INTESTINE FUNCTION DISORDER; LOW INCOME COUNTRY; MALNUTRITION; NONHUMAN; NUTRITION; PATHOGENESIS; REVIEW; CAMPYLOBACTERIOSIS; COMPLICATION; DEVELOPING COUNTRY; GROWTH DISORDER; IMMUNOLOGY; INFANTILE DIARRHEA; MICROBIOLOGY; PATHOGENICITY;

CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; DEVELOPING COUNTRIES; DIARRHEA, INFANTILE; GASTROINTESTINAL MICROBIOME; GROWTH DISORDERS; HUMANS; INFANT;

EID: 85011715786     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0000000000000364     Document Type: Review

References (48)

1. WHO. The global view of campylobacteriosis. WHO Press; 2012; ISBN 9789241564601. Available at: www.who.int.
2. Blaser MJ. Epidemiologic and clinical features of Campylobacter jejuni infections. J InfectDis 1997;176:S103-S105.
3. Allos BM. Campylobacter jejuni infections: update on emerging issues and trends. Clin Infect Dis 2001;32:1201-1206.
4. Amour C, Gratz J, Mduma E, et al., Etiology, Risk Factors, and Interactions of Enteric Infections and Malnutrition and the Consequences for Child Health and Development Project (MAL-ED) Network Investigators. Epidemiology and impact of campylobacter infection in children in 8 low-resource settings: results from the MAL-ED study. Clin Infect Dis 2016;63:1171-1179. This study demonstrates the nearly ubiquitous nature of C. jejuni among children in developing countries and its association with growth faltering.
5. Chang C, Miller JF. Campylobacter jejuni colonization of mice with limited enteric flora. Infect Immun 2006;74:5261-5271.
6. Rathinam VAK, Hoag KA, Mansfield LS. Dendritic cells from C57BL/6 mice undergo activation and induce Th1-effector cell responses against Campy-lobacter jejuni. Microbes Infect 2008;10:1316-1324.
7. Friis LM, Keelan M, Taylor DE. Campylobacter jejuni drives MyD88-indepen-dent interleukin-6 secretion via Toll-like receptor 2. Infect Immun 2009;77:1553-1560.
8. Rathinam VAK, Appledorn DM, Hoag KA, et al. Campylobacter jejuni-induced activation of dendritic cells involves cooperative signaling through Toll-like receptor 4 (TLR4)-MyD88 and TLR4-TRIF axes. Infect Immun 2009;77:2499-2507.
9. Edwards LA, Nistala K, Mills DC, et al. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection. PLoS One 2010;5:e15398.
10. O'Hara JR, Feener TD, Fischer CD, Buret AG. Campylobacter jejuni disrupts protective Toll-like receptor 9 signaling in colonic epithelial cells and increases the severity of dextran sulfate sodium-induced colitis in mice. Infect Immun 2012;80:1563-1571.
11. Stahl M, Ries J, Vermeulen J, et al. A novel mouse model of Campylobacter jejuni gastroenteritis reveals key pro-inflammatory and tissue protective roles for Toll-like receptor signaling during infection. PLoS Pathog 2014;10:9-11.
12. Stahl M, Vallance BA. Insights into Campylobacter jejuni colonization of the mammalian intestinal tract using a novel mouse model of infection. Gut Microbes 2015;6:143-148. This study demonstrates specific interactions of C. jejuni with the host and subsequent immune response via a single IgG IL-1-related receptor-deficient mouse model, providing new opportunities for the study of this bacteria.
13. Hickey TE, Majam G, Guerry P. Intracellular survival of Campylobacter jejuni in human monocytic cells and induction of apoptotic death by cytholethal distending toxin. Infect Immun 2005;73:5194-5197.
14. Hofreuter D, Novik V, Galán JE. Metabolic diversity in Campylobacter jejuni enhances specific tissue colonization. Cell Host Microbe 2008;4:425-433.
15. Bereswill S, Fischer S, Plickert R, et al. Novel murine infection models provide deep insights into the 'Ménage à trois' of Campylobacter jejuni, microbiota and host innate immunity. PLoS One 2011;6:e20953.
16. Haag LM, Fischer A, Otto B, et al. Campylobacter jejuni infection of infant mice: acute enterocolitis is followed by asymptomatic intestinal and extra-intestinal immune responses. Eur J Microbiol Immunol 2012;2:2-11.
17. Haag LM, Fischer A, Otto B, et al. Intestinal microbiota shifts towards elevated commensal Escherichia coli loads abrogate colonization resistance against Campylobacter jejuni in mice. PLoS One 2012;7:e35988.
18. O'Loughlin JL, Samuelson DR, Braundmeier-Fleming AG, et al. The intestinal microbiota influences Campylobacter jejuni colonization and extraintestinal dissemination in mice. Appl Environ Microbiol 2015;81:4642-4650. This study demonstrates how colonization resistance to C. jejuni, afforded by the murine microbiota, can be overcome with ampicillin pretreatment, providing new opportunities for investigative models.
19. Lee G, Pan W, Peñataro Yori P, et al. Symptomatic and asymptomatic Campylobacter infections associated with reduced growth in Peruvian children. PLoS Negl Trop Dis 2013;7:e2036.
20. Platts-Mills JA, Babji S, Bodhidatta L, et al. Pathogen-specific burdens of community diarrhoea in developing countries: a multisite birth cohort study (MAL-ED). Lancet Glob Heal 2015;3:e564-e575.
21. Attia S, Versloot CJ, Voskuijl W, et al. Mortality in children with complicated severe acute malnutrition is related to intestinal and systemic inflammation: an observational cohort study. Am J Clin Nutr 2016;104:1441-1449. This study demonstrates the immediate link between heightened inflammation and mortality in malnutrition, reinforcing the interplay among diet, pathogens and host response in the development of environmental enteric dysfunction (EED).
22. Sung J, Morales W, Kim G, et al. Effect of repeated Campylobacter jejuni infection on gut flora and mucosal defense in a rat model of post infectious functional and microbial bowel changes. Neurogastroenterol Motil 2013;25:529-537.
23. Keithlin J, Sargeant JM, Thomas MK, Fazil A. Systematic review and meta-analysis of the proportion of nontyphoidal Salmonella cases that develop chronic sequelae. Epidemiol Infect 2015;143:1333-1351.
24. Platts-Mills JA, Liu J, Gratz J, et al. Detection of Campylobacter in stool and determination of significance by culture, enzyme immunoassay, and PCR in developing countries. J Clin Microbiol 2014;52:1074-1080.
25. Masanta WO, Heimesaat MM, Bereswill S, et al. Modification of intestinal microbiota and its consequences for innate immune response in the pathogenesis of campylobacteriosis. Clin Dev Immunol 2013;2013:526860.
26. Dasti JI, Tareen AM, Lugert R, et al. Campylobacter jejuni: a brief overview on pathogenicity-associated factors and disease-mediating mechanisms. Int J Med Microbiol 2010;300:205-211.
27. Fouts DE, Mongodin EF, Mandrell RE, et al. Major structural differences and novel potential virulence mechanisms from the genomes of multiple campy-lobacter species. PLoS Biol 2005;3:72-85.
28. Konkel ME, Monteville MR, Rivera-Amill V, Joens LA. The pathogenesis of Campylobacter jejuni-mediated enteritis. Curr Issues Intest Microbiol 2001;2:55-71.
29. Watson RO, Galán JE. Campylobacter jejuni survives within epithelial cells by avoiding delivery to lysosomes. PLoS Pathog 2008;4:0069-0083.
30. Rose A, Kay E, Wren BW, Dallman MJ. The Campylobacter jejuni NCTC11168 capsule prevents excessive cytokine production by dendritic cells. Med Microbiol Immunol 2012;201:137-144.
31. Fäis T, Delmas J, Serres A, et al. Impact of CDT toxin on human diseases. Toxins (Basel) 2016;8:220-232.
32. Zheng J, Meng J, Zhao S, et al. Campylobacter-induced interleukin-8 secretion in polarized human intestinal epithelial cells requires Campylobacter-secreted cytolethal distending toxin- and Toll-like receptor-mediated activation of NF-KB. Infect Immun 2008;76:4498-4508.
33. Hu L, Hickey TE. Campylobacter jejuni induces secretion of proinflammatory chemokines from human intestinal epithelial cells. Infect Immun 2005;73:4437-4440.
34. Zilbauer M, Dorrell N, Elmi A, et al. A major role for intestinal epithelial nucleotide oligomerization domain 1 (NOD1) in eliciting host bactericidal immune responses to Campylobacter jejuni. Cell Microbiol 2007;9:2404-2416.
35. Bourke B. Campylobacter infection: small bowel and colon. Curr Opin Gastroenterol 2002;18:4-9.
36. Watanabe K, Petri WA. Environmental enteropathy: elusive but significant subclinical abnormalities in developing countries. EBioMedicine 2016;10:25-32. This article provides a review of EED, including pathogenesis, its role in outcomes like oral vaccine failure and proposed therapies, detailing poorly understood facets of this disease.
37. Petri WA, Naylor C, Haque R. Environmental enteropathy and malnutrition: do we know enough to intervene? BMC Med 2014;12:187-192.
38. Keusch GT, Denno DM, Black RE, et al. Environmental enteric dysfunction: pathogenesis, diagnosis, and clinical consequences. Clin Infect Dis 2014;59:S207-S212.
39. Liu J, Bolick DT, Kolling GL, et al. Protein malnutrition impairs intestinal epithelial cell turnover, a potential mechanism of increased cryptosporidiosis in a murine model. Infect Immun 2016;84:3542-3549.
40. Hossain I, Haque R, Mondal D, et al. Undernutrition, vitamin A and iron deficiency are associated with impaired intestinal mucosal permeability in young Bangladeshi children assessed by lactulose/mannitol test. PLoS Onev 2016;11:1-10.
41. Naylor C, Lu M, Haque R, et al. Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh. EBioMedicine 2015;2:1759-1766. This study demonstrates that EED and systemic inflammation are associated with oral vaccine failure and growth faltering for infants in Bangladesh.
42. Bereswill S, Pickert R, et al. What you eat is what you get: novel Campy-lobacter models in the quadrangle relationship between nutrition, obesity, microbiota and susceptibility to infection. Eur J Microbiol Immunol (Bp) 2011;1:237-248.
43. Grover M, Camilleri M, Smith K, et al. Postinfectious irritable bowel syndrome: mechanisms related to pathogens. Neurogastroenterol Motil 2014;26:156-167.
44. Brown EM, Wlodarska M, Willing BP, et al. Diet and specific microbial exposure trigger features of environmental enteropathy in a novel murine model. Nat Commun 2015;6:1-16.
45. Heimesaat MM, Haag LM, Fischer A, et al. Survey of extra-intestinal immune responses in asymptomatic long-term Campylobacter jejuni-infected mice. Eur J Microbiol Immunol (Bp) 2013;3:174-182.
46. Burgess SL, Buonomo E, Carey M, et al. Bone marrow dendritic cells from mice with an altered microbiota provide interleukin 17A-dependent protection against Entamoeba histolytica colitis. MBio 2014;5:e01817.
47. Kleinnijenhuis J, Quintin J, Preijers F, et al. Bacille Calmette-Guérin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes. Proc Natl Acad Sci U S A 2012;109:17537-17542.
48. Netea MG, Quintin J, van der Meer JW. Trained immunity: a memory for innate host defense. Cell Host Microbe 2011;9:355-361.